website logo
side menu icon

Fund Manager

Aditum Bio

Back
AB
Aditum Bio

Fund Manager

Primary Strategy: Venture Capital

Year Founded: 2019

Number of Employees: 53

Ownership: Privately Held

Year End: December

Description

Aditum Bio is a biotech venture capital firm launched in 2019 by former Novartis leaders, Joe Jimenez and Dr. Mark Fishman. It aims to provide access to medicines by rapidly translating scientific discoveries into new drugs for underserved patients. Aditum Bio forms and staffs companies with experts to develop clinic-ready therapies and manages a portfolio of clinical stage companies.

Contact

Website: Link to website

LinkedIn: linkedin.com/company/aditum-bio

Address

1111 Broadway, Suite 1300, Oakland, California, United States

Date

As of: September 30, 2025

Key Metrics

See data over time

{{ metric.value.toLocaleString() }}

{{ metric.details.label }}

{{ metric.details.desc }}

Office Locations

Business mix

Mix of Private Fund AUM ($M)

By geography
By strategy
By fund size
By fund vintage

Leadership and Fund Service Providers

Key Management

{{ leader.name }}

{{ leader.value ?? '-' }}

Fund Service Providers

{{ provider.name ?? '-' }}

{{ provider.value ?? '-' }}

{{ provider.value ?? '-' }}

Key Metrics

Table view

No matching search results

We couldn't find any results for your search. Please check your spelling or try using different keywords. Please Try Again

{{ heading }}
{{ cell.label }} {{ cell.desc }} {{ typeof(cell) === 'number' ? cell.toLocaleString() : cell }} {{ '-' }}

Key Metrics

Chart view

{{ metricFilters[selectedMetric] }}
{{ label }}

No matching search results

We couldn't find any results for your search. Please check your spelling or try using different keywords. Please Try Again

Top {{ pagination.total }} {{ pagination.total === 1 ? 'Fund' : 'Funds' }}

Top fund structures by AUM

No matching search results

We couldn't find any results for your search. Please check your spelling or try using different keywords. Please Try Again

{{ heading.label }} {{ heading.desc }}
{{ cell }} {{ !isNaN(cell) ? Number(cell).toLocaleString() + (headingData.find(h => h.field === cellName)?.label.includes('%') ? ' %' : '') : (cell.length > 60 ? cell.substring(0, 60) + '...' : cell) }} {{ '-' }}
See All Funds

Current Service Providers

No matching search results

We couldn't find any results for your search. Please check your spelling or try using different keywords. Please Try Again

{{ heading.label }} {{ heading.desc }}
{{ cell }} {{ !isNaN(cell) ? Number(cell).toLocaleString() + (headingData.find(h => h.field === cellName)?.label.includes('%') ? ' %' : '') : (cell.length > 60 ? cell.substring(0, 60) + '...' : cell) }} {{ '-' }}

No matching search results

We couldn't find any results for your search. Please check your spelling or try using different keywords. Please Try Again

{{ heading.label }} {{ heading.desc }}
{{ cell }} {{ !isNaN(cell) ? Number(cell).toLocaleString() + (headingData.find(h => h.field === cellName)?.label.includes('%') ? ' %' : '') : (cell.length > 60 ? cell.substring(0, 60) + '...' : cell) }} {{ '-' }}

Switches

Last 12 months

{{ filterByOptions[currentFilter] }}
{{ name }}

No matching search results

We couldn't find any results for your search. Please check your spelling or try using different keywords. Please Try Again

{{ heading.label }} {{ heading.desc }}
{{ cell }} {{ !isNaN(cell) ? Number(cell).toLocaleString() + (headingData.find(h => h.field === cellName)?.label.includes('%') ? ' %' : '') : (cell.length > 60 ? cell.substring(0, 60) + '...' : cell) }} {{ '-' }}

Questions relating to our data?

Singularity is a subscription-based data platform with data on the private fund industry. Contact us with any questions about this profile or for a demo of our full platform.

Contact Us
homepage showcase image